IL-19 has been proposed as a member of the inflammatory IL-23A/IL-17A cascade in psoriasis; its upregulation in keratinocytes is driven by IL-17A, and it acts in an autocrine fashion on keratinocytes to amplify the effects of IL-17A (31). Here, IL23A is linked to psoriasis.